BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Coagulation, Allergy to pollen, Adipose tissue, Personalized medicine, Fenofibrate)
Bookmark Forward

QuickView for CR1 (gene)


Body Atlas

Most Correlated Tissues

  1. Leukocyte (polymorphonuclear) of peripheral blood
  2. Neutrophil of bone marrow
  3. B lymphocyte (IgM memory) of spleen
  4. Eosinophil of peripheral blood
  5. Basophil of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Complement deficiency disease
  2. Anthrax
  3. Sepsis due to Escherichia coli
  4. Malaria
  5. Acne
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Biperiden
  2. Idazoxan
  3. Am 580
  4. Practolol
  5. Pantothenic Acid
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. BACH2
  2. LCP2
  3. GNB1
  4. ALDH3B1
  5. RBM25
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease…
  2. The Molecular Mechanisms of Complement Receptor 1-It Is Complicated.
  3. Mechanistic insights into complement pathway inhibition by CR1 domain duplication.
  4. Complement Receptor 1 Is a Potential Extracerebral Factor Promoting α-Synuclein Pathology.
  5. Complement Receptor 1 Enhancement in Recurrent Membranous Nephropathy Following Kidney Transplantati…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
  2. Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in C…
  3. CNDO-109-AANK for AML in First Complete Remission (CR1)
  4. Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (…
  5. 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk A…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.